1.Standardized Pathology Report for Colorectal Cancer, 2nd Edition
Baek-hui KIM ; Joon Mee KIM ; Gyeong Hoon KANG ; Hee Jin CHANG ; Dong Wook KANG ; Jung Ho KIM ; Jeong Mo BAE ; An Na SEO ; Ho Sung PARK ; Yun Kyung KANG ; Kyung-Hwa LEE ; Mee Yon CHO ; In-Gu DO ; Hye Seung LEE ; Hee Kyung CHANG ; Do Youn PARK ; Hyo Jeong KANG ; Jin Hee SOHN ; Mee Soo CHANG ; Eun Sun JUNG ; So-Young JIN ; Eunsil YU ; Hye Seung HAN ; Youn Wha KIM ;
Journal of Pathology and Translational Medicine 2020;54(1):1-19
The first edition of the ‘Standardized Pathology Report for Colorectal Cancer,’ which was developed by the Gastrointestinal Pathology Study Group (GIP) of the Korean Society of Pathologists, was published 13 years ago. Meanwhile, there have been many changes in the pathologic diagnosis of colorectal cancer (CRC), pathologic findings included in the pathology report, and immunohistochemical and molecular pathology required for the diagnosis and treatment of colorectal cancer. In order to reflect these changes, we (GIP) decided to make the second edition of the report. The purpose of this standardized pathology report is to provide a practical protocol for Korean pathologists, which could help diagnose and treat CRC patients. This report consists of “standard data elements” and “conditional data elements.” Basic pathologic findings and parts necessary for prognostication of CRC patients are classified as “standard data elements,” while other prognostic factors and factors related to adjuvant therapy are classified as “conditional data elements” so that each institution could select the contents according to the characteristics of the institution. The Korean version is also provided separately so that Korean pathologists can easily understand and use this report. We hope that this report will be helpful in the daily practice of CRC diagnosis.
2.Robotic Single-Site Hysterectomy versus Robot-Assisted Multiport Hysterectomy in Benign Gynecologic Diseases: A Retrospective Comparison of Clinical and Surgical Outcomes.
Ye Hyon PARK ; Se Hee PARK ; Ryeo Bin LEE ; Hye Yon CHO ; Jung Bae KANG ; Pong Rheem JANG ; Min Sun KYUNG
Soonchunhyang Medical Science 2018;24(1):22-27
OBJECTIVE: The purpose of this study was to compare clinical and surgical outcomes of robotic single-site hysterectomy (RSSH) and robot-assisted multiport hysterectomy (RH) in benign disease. METHODS: We retrospectively reviewed the medical records of 38 women who underwent RSSH (N=12) or RH (N=26) for the treatment of benign uterine disease between June 2015 and November 2017. RESULTS: There were no intergroup differences in parity, comorbidities, and number of previous abdominal surgery. Mean age was older (49.5±5.05 years vs. 44.4±3.54 years, P=0.001) and mean body mass index was higher (27.4±2.47 kg/m2 vs. 25.3±3.12 kg/m2, P=0.045) in RSSH group than RH group. Surgical outcomes, including operative time (165.0 minutes vs. 159.2 minutes, P=0.727), estimated blood loss (115.8±33.15 mL vs. 108.1±56.42 mL, P=0.662), uterus weight (445.9±157.21 g vs. 374.5±197.91 g, P=0.291), postoperative hospital stay (5.4±0.51 days vs. 5.8±1.20 days, P=0.289), postoperative hemoglobin change in day 1 (1.8±0.89 g/dL vs. 1.4±1.53 g/dL, P=0.431) and day 3 (2.1±1.32 g/dL vs. 1.7±1.83 g/dL, P=0.601), and perioperative complications did not significantly differ between two groups. The use of additional analgesics after 6 hours, 24 hours, and 48 hours, and mean NRS score after 6 hours, 24 hours, and 48 hours were not significantly different between two groups. CONCLUSION: RSSH might be an effective and safe alternative to RH, even if in older and/or obese women with large uteri.
Analgesics
;
Body Mass Index
;
Comorbidity
;
Female
;
Genital Diseases, Female*
;
Humans
;
Hysterectomy*
;
Length of Stay
;
Medical Records
;
Minimally Invasive Surgical Procedures
;
Operative Time
;
Parity
;
Retrospective Studies*
;
Robotic Surgical Procedures
;
Uterine Diseases
;
Uterus
3.Molecular Testing for Gastrointestinal Cancer.
Hye Seung LEE ; Woo Ho KIM ; Yoonjin KWAK ; Jiwon KOH ; Jeong Mo BAE ; Kyoung Mee KIM ; Mee Soo CHANG ; Hye Seung HAN ; Joon Mee KIM ; Hwal Woong KIM ; Hee Kyung CHANG ; Young Hee CHOI ; Ji Y PARK ; Mi Jin GU ; Min Jin LHEE ; Jung Yeon KIM ; Hee Sung KIM ; Mee Yon CHO
Journal of Pathology and Translational Medicine 2017;51(2):103-121
With recent advances in molecular diagnostic methods and targeted cancer therapies, several molecular tests have been recommended for gastric cancer (GC) and colorectal cancer (CRC). Microsatellite instability analysis of gastrointestinal cancers is performed to screen for Lynch syndrome, predict favorable prognosis, and screen patients for immunotherapy. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor has been approved in metastatic CRCs with wildtype RAS (KRAS and NRAS exon 2–4). A BRAF mutation is required for predicting poor prognosis. Additionally, amplification of human epidermal growth factor receptor 2 (HER2) and MET is also associated with resistance to EGFR inhibitor in metastatic CRC patients. The BRAF V600E mutation is found in sporadic microsatellite unstable CRCs, and thus is helpful for ruling out Lynch syndrome. In addition, the KRAS mutation is a prognostic biomarker and the PIK3CA mutation is a molecular biomarker predicting response to phosphoinositide 3-kinase/AKT/mammalian target of rapamycin inhibitors and response to aspirin therapy in CRC patients. Additionally, HER2 testing should be performed in all recurrent or metastatic GCs. If the results of HER2 immunohistochemistry are equivocal, HER2 silver or fluorescence in situ hybridization testing are essential for confirmative determination of HER2 status. Epstein-Barr virus–positive GCs have distinct characteristics, including heavy lymphoid stroma, hypermethylation phenotype, and high expression of immune modulators. Recent advances in next-generation sequencing technologies enable us to examine various genetic alterations using a single test. Pathologists play a crucial role in ensuring reliable molecular testing and they should also take an integral role between molecular laboratories and clinicians.
4.Occupational Risk of Latent Tuberculosis Infection in Health Workers of 14 Military Hospitals.
Chang Gyo YOON ; Soo Yon OH ; Jin Beom LEE ; Mi Hyun KIM ; Younsuk SEO ; Juyoun YANG ; Kyu Jung BAE ; Seoyean HONG ; Eun Suk YANG ; Hee Jin KIM
Journal of Korean Medical Science 2017;32(8):1251-1257
Tuberculosis (TB) is a known occupational risk to health workers. Identifying risk factors in health care settings is critical to the prevention of TB for health workers and patients. In 2014, we carried out a TB screening and survey for 902 health workers from 14 selected military hospitals to determine the prevalence rate of latent tuberculosis infection (LTBI) as well as occupational risk factors. Of all subjects, 19.5% reported having provided TB patient care for 1 year or more (176/902), and 26.9% (243/902) were positive for the tuberculin skin test (TST) (10 mm or more of induration). Additionally, 21.4% (52/243) of those who tested positive were also positive for the interferon-gamma release assay (IGRA). The proportion of LTBI in the study population was 5.8% (52/902). In a multivariate logistic regression analysis, providing TB patient care for one year or more was the only significant occupational risk factor (adjusted odds ratio [aOR], 2.27; 95% confidence interval [CI], 1.13–4.56). This study suggests that military health workers working with TB patients should be regularly examined by chest radiography, TST and IGRA to detect LTBI in the early stage and control nosocomial infection of TB.
Cross Infection
;
Delivery of Health Care
;
Hospitals, Military*
;
Humans
;
Interferon-gamma Release Tests
;
Latent Tuberculosis*
;
Logistic Models
;
Mass Screening
;
Military Personnel*
;
Occupational Exposure
;
Odds Ratio
;
Patient Care
;
Prevalence
;
Radiography
;
Risk Factors
;
Skin Tests
;
Thorax
;
Tuberculin
;
Tuberculosis
5.Anti-atherosclerotic effects of perilla oil in rabbits fed a high-cholesterol diet.
Yeseul CHA ; Ja Young JANG ; Young Hwan BAN ; Haiyu GUO ; Kyungha SHIN ; Tae Su KIM ; Sung Pyo LEE ; Jieun CHOI ; Eun Suk AN ; Da Woom SEO ; Jung Min YON ; Ehn Kyoung CHOI ; Yun Bae KIM
Laboratory Animal Research 2016;32(3):171-179
Anti-atherosclerosis effects of perilla oil were investigated, in comparison with lovastatin, in rabbits fed a high-cholesterol diet (HCD). Hypercholesterolemia was induced in rabbits by feeding the HCD containing 0.5% cholesterol and 1% corn oil, and perilla oil (0.1 or 0.3%) was added to the diet containing 0.5% cholesterol for 10 weeks. HCD greatly increased blood total cholesterol and low-density lipoproteins, and caused thick atheromatous plaques, covering 74% of the aortic wall. Hyper-cholesterolemia also induced lipid accumulation in the liver and kidneys, leading to lipid peroxidation. Perilla oil not only attenuated hypercholesterolemia and atheroma formation, but also reduced fat accumulation and lipid peroxidation in hepatic and renal tissues. The results indicate that perilla oil prevents atherosclerosis and fatty liver by controlling lipid metabolism, and that it could be the first choice oil to improve diet-induced metabolic syndrome.
Atherosclerosis
;
Cholesterol
;
Corn Oil
;
Diet*
;
Fatty Liver
;
Hypercholesterolemia
;
Kidney
;
Lipid Metabolism
;
Lipid Peroxidation
;
Lipoproteins, LDL
;
Liver
;
Lovastatin
;
Perilla*
;
Plaque, Atherosclerotic
;
Rabbits*
6.Comparison of Surrogate Markers as Measures of Uncomplicated Insulin Resistance in Korean Adults.
Tae Jong KIM ; Hye Jung KIM ; Young Bae KIM ; Jee Yon LEE ; Hye Sun LEE ; Jung Hwa HONG ; Ji Won LEE
Korean Journal of Family Medicine 2016;37(3):188-196
BACKGROUND: Metabolic syndrome (MS) is known to increase the risk of various cardiometabolic diseases and in-sulin resistance (IR) has known to have central role in the development of MS. Many surrogate indices of IR have been proposed and the detection of MS might be a suitable model for assessing the accuracy of surrogate indices. The aims of our study are to invest the most appropriate index by assessment of the diagnostic capacity of IR among each surrogate index and identifying cut-off values for discriminating uncomplicated MS in Korean adults. METHODS: A cross-sectional study was performed, assessing 294 Korean adults, 85 of whom were diagnosed with uncomplicated MS. The sensitivities and specificities of five surrogate IR indices were compared to discriminate MS from healthy subjects; these included fasting serum insulin, homeostasis model assessment-insulin resistance index, quantitative insulin sensitivity check index, McAuley index, and Disse index. Correlations between each index value were assessed using Pearson's and Spearman's correlation methods. RESULTS: The McAuley index showed the highest area under the curve (0.85), specificity (86.12%), accuracy (82.31%), positive predictive value (68.13%), and negative predictive value (88.67%) to distinguish MS, with a cut-off point of 5.3 defined. Correlation coefficients of the five indices showed that the McAuley index had the strongest correlation with IR. CONCLUSION: The McAuley index showed the best accuracy in the detection of MS as a surrogate marker of IR. To establish more effective and accurate standards of measuring IR, comprehensive and multi-scaled studies are required.
Adult*
;
Asian Continental Ancestry Group
;
Biomarkers*
;
Cross-Sectional Studies
;
Fasting
;
Healthy Volunteers
;
Homeostasis
;
Humans
;
Insulin Resistance*
;
Insulin*
;
Sensitivity and Specificity
7.Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
Hye Yon CHO ; Sung Ho PARK ; Young Han PARK ; Hong Bae KIM ; Jung Bae KANG ; Seung Hwa HONG ; Min Sun KYUNG
Journal of Korean Medical Science 2015;30(12):1777-1783
This study is a multi-center clinical study, which aimed to compare CA125, HE4, and risk of ovarian malignancy algorithm (ROMA) in predicting epithelial ovarian cancer of Korean women with a pelvic mass. Prospectively, serum from 90 Korean women with ovarian mass was obtained prior to surgery. For control group, serum from 79 normal populations without ovarian mass was also obtained. The HE4 and CA125 data were registered and evaluated separately and ROMA was calculated for each sample. Total 67 benign tumors and 23 ovarian cancers were evaluated. Median serum levels of HE4 and CA125, and ROMA score were significantly higher in patients with ovarian cancer than those with benign ovarian tumor and normal population (P < 0.001). In ROC curve analysis for women with a pelvic mass, area under the curve (AUC) for HE4 and ROMA was higher than CA125. Statistical differences in each study compared to CA125 were marginal (P compared to CA125; 0.082 for HE4 and 0.069 for ROMA). Sub-analysis revealed that AUC for HE4 and ROMA was higher than AUC for CA125 in post-menopausal women with a pelvic mass, but there were no statistically significant differences (P compared to CA125; 0.160 for HE4 and 0.127 for ROMA). Our data suggested that both HE4 and ROMA score showed better performance than CA125 for the detection of ovarian cancer in women with a pelvic mass. HE4 and ROMA can be a useful independent diagnostic marker for epithelial ovarian cancer in Korean women.
Algorithms
;
Area Under Curve
;
Biomarkers, Tumor/blood
;
CA-125 Antigen/*blood
;
Case-Control Studies
;
Female
;
Humans
;
Middle Aged
;
Neoplasms, Glandular and Epithelial/*blood/*diagnosis
;
Ovarian Neoplasms/*blood/*diagnosis
;
Predictive Value of Tests
;
Prospective Studies
;
Proteins/*metabolism
;
ROC Curve
;
Reference Values
;
Republic of Korea
8.Interleukin-21 Receptor Gene Polymorphisms in Kawasaki Disease.
Mi Hyun KIM ; Yon Jung BAE ; Hyun Keun LEE ; Yeong Ro LEE ; Dong Hoon LEE ; Kiho BAE ; Sang Baek KOH ; Mee Kyung NAMGOONG ; Byung Ho CHA ; Hae Yong LEE
Korean Circulation Journal 2013;43(1):38-43
BACKGROUND AND OBJECTIVES: Interleukin-21 receptor (IL-21R) gene polymorphism is related with the development of systemic vasculitis. In this study, we investigated the polymorphisms of IL-21R gene in patients with Kawasaki disease (KD). SUBJECTS AND METHODS: We genotyped the promoter region of IL-21R gene (-2500 bp to +1 bp) in 100 patients with KD and 100 healthy controls. All study subjects were Korean. We designed five pairs of primers and performed polymerase chain reaction (PCR) and direct sequencing. We analyzed whole promoter sequences of 200 individuals with comparison to reference sequences of IL-21R gene (NG_012222.1/NC_000016.9). RESULTS: We found five single nucleotide polymorphisms (SNPs) of which minor allele frequency (MAF) >0.01 in the promoter region of IL-21R gene. Those are -1681 G>T (chromosome site 27411802), -379 G>A (27413104), -332 G>C (27413151, rs2214537), -237 A>T (27413246), and -53 G>A (27413430). There is no significant difference in MAF of each SNP between patients with KD and healthy controls except -237 A>T. Twenty five patients with KD had more than 1 SNP in contrast to only seven healthy controls had. The patients with KD have significantly more IL-21R gene polymorphisms than controls (odds ratio: 3.0, 95% confidence interval: 1.6-5.6, p=0.0005). There was no significant correlation between IL-21R gene polymorphisms and the serum level of IL-21. The serum level of total IgE was not significantly correlated with the presence of IL-21R gene polymorphisms. CONCLUSION: Our data suggest that the genetic susceptibility profile for KD may include IL-21R gene.
Gene Frequency
;
Genetic Predisposition to Disease
;
Humans
;
Immunoglobulin E
;
Interleukins
;
Mucocutaneous Lymph Node Syndrome
;
Polymerase Chain Reaction
;
Polymorphism, Genetic
;
Polymorphism, Single Nucleotide
;
Promoter Regions, Genetic
;
Receptors, Interleukin-21
;
Systemic Vasculitis
9.Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.
Mee Yon CHO ; Joon Mee KIM ; Jin Hee SOHN ; Mi Jung KIM ; Kyoung Mee KIM ; Woo Ho KIM ; Hyunki KIM ; Myeong Cherl KOOK ; Do Youn PARK ; Jae Hyuk LEE ; Heekyung CHANG ; Eun Sun JUNG ; Hee Kyung KIM ; So Young JIN ; Joon Hyuk CHOI ; Mi Jin GU ; Sujin KIM ; Mi Seon KANG ; Chang Ho CHO ; Moon Il PARK ; Yun Kyung KANG ; Youn Wha KIM ; Sun Och YOON ; Han Ik BAE ; Mee JOO ; Woo Sung MOON ; Dae Young KANG ; Sei Jin CHANG
Cancer Research and Treatment 2012;44(3):157-165
PURPOSE: As a result of various independently proposed nomenclatures and classifications, there is confusion in the diagnosis and prediction of biological behavior of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A comprehensive nationwide study is needed in order to understand the biological characteristics of GEP-NETs in Korea. MATERIALS AND METHODS: We collected 4,951 pathology reports from 29 hospitals in Korea between 2000 and 2009. Kaplan-Meier survival analysis was used to determine the prognostic significance of clinicopathological parameters. RESULTS: Although the GEP-NET is a relatively rare tumor in Korea, its incidence has increased during the last decade, with the most significant increase found in the rectum. The 10-year survival rate for well-differentiated endocrine tumor was 92.89%, in contrast to 85.74% in well differentiated neuroendocrine carcinoma and 34.59% in poorly differentiated neuroendocrine carcinoma. Disease related death was most common in the biliary tract (62.2%) and very rare in the rectum (5.2%). In Kaplan-Meier survival analysis, tumor location, histological classification, extent, size, mitosis, Ki-67 labeling index, synaptophysin expression, lymphovascular invasion, perineural invasion, and lymph node metastasis showed prognostic significance (p<0.05), however, chromogranin expression did not (p=0.148). The 2000 and 2010 World Health Organization (WHO) classification proposals were useful for prediction of the prognosis of GEP-NET. CONCLUSION: The incidence of GEP-NET in Korea has shown a remarkable increase during the last decade, however, the distribution of tumors in the digestive system differs from that of western reports. Assessment of pathological parameters, including immunostaining, is crucial in understanding biological behavior of the tumor as well as predicting prognosis of patients with GEP-NET.
Biliary Tract
;
Carcinoma, Neuroendocrine
;
Digestive System
;
Humans
;
Incidence
;
Intestinal Neoplasms
;
Korea
;
Lymph Nodes
;
Mitosis
;
Neoplasm Metastasis
;
Neuroendocrine Tumors
;
Pancreatic Neoplasms
;
Population Characteristics
;
Prognosis
;
Rectum
;
Stomach Neoplasms
;
Survival Rate
;
Synaptophysin
;
World Health Organization
10.Plasma Real Time-Quantitative Polymerase Chain Reaction of Epstein-Barr Virus in Immunocompetent Patients with Hepatitis.
Ji Hye HONG ; Yon Jung BAE ; Joon Hyung SOHN ; Byung Il YE ; Jin Kyong CHUN ; Hwang Min KIM
Pediatric Gastroenterology, Hepatology & Nutrition 2012;15(1):38-43
PURPOSE: Epstein-Barr virus (EBV) hepatitis is a usually asymptomatic and self-limiting disease in immunocompetent patients. However, the range of severity is wide, and the serological diagnosis is typically difficult until the convalescent phase. Thus, we examined the value of plasma EBV DNA real-time quantitative polymerase chain reaction (RT-qPCR) in EBV hepatitis for the timely diagnosis and the relationship between EBV viral load and clinical severity. METHODS: Sixty samples were confirmed as having EBV infection by RT-qPCR with the EBV BALF5 gene sequence. We examined the clinical characteristics of EBV hepatitis by reviewing medical records. RESULTS: The median total duration of fever was 8 days (range: 0-13 days). The mean peak value of aspartate aminotransferase (AST) was 241+/-214 U/L, and the mean peak value of alanine aminotransferase (ALT) was 298+/-312 U/L. There was no correlation between the serum levels of liver enzyme and plasma EBV DNA titer (p=0.1) or between median total duration of fever and EBV DNA titer (p=0.056). The median age of the EBV VCA IgM-negative group was lower compared with the EBV VCA IgM-positive group in EBV hepatitis (2 years vs. 6 years, p=0.0009). CONCLUSION: The severity of EBV hepatitis does not correlate with circulating EBV DNA load according to our data. Furthermore, we suggest that plasma EBV PCR may be valuable in young infants in whom the results of serology test for EBV infection commonly are negative.
Alanine Transaminase
;
Aspartate Aminotransferases
;
DNA
;
Epstein-Barr Virus Infections
;
Fever
;
Hepatitis
;
Herpesvirus 4, Human
;
Humans
;
Infant
;
Liver
;
Plasma
;
Polymerase Chain Reaction
;
Viral Load

Result Analysis
Print
Save
E-mail